<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Point mutations in the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor gene are the most frequently identified genetic alterations in human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In order to evaluate the role of p53 mutations in the multistep process of <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> we studied 61 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> using single-strand conformation polymorphism analysis of polymerase chain reaction products as well as direct sequencing </plain></SENT>
<SENT sid="2" pm="."><plain>Mutant alleles were observed in 1/14 <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and 2/5 RAEB in transformation </plain></SENT>
<SENT sid="3" pm="."><plain>The three mutations represented G:C to A:T transitions at codon 141 (exon 5) and codons 245 and 248 (exon 7), respectively </plain></SENT>
<SENT sid="4" pm="."><plain>These data suggest that p53 mutations may contribute, albeit rarely, to the development of preleukemic disorders of the myeloid cell lineage </plain></SENT>
</text></document>